Proteolytic removal of the pre-segment from growing nascent chains of pre-human placental lactogen (hPL) occurred during in vitro translation of placental mRNA if crude membranes derived from ascites lysates, dog pancreas, or rat liver rough endoplasmic reticulum were add to the translation mixtures. The cotranslational proteolytic event was inhibited by the peptide protease inhibitor, chymostatin, but not by leupeptin, antipain, or elastatinal. The proteases involved in cleavage were solubilized with detergent and converted completed pre-hPL to hPL (post-translational processing). Direct assay of the solubilized membranes, with synthetic fluorogenic aminocoumarin peptide substrates, revealed no significant tryptic or elastase-like activity, but activity against a chymotrypsin substrate [(succinyl-Ala-Ala-Phe)7-amino-4-methylcoumarinj was found. This activity was dependent upon both an endopeptidase and an aminopeptidase. Although bestatin inhibited the aminopeptidase activity, it had no effect on the endopeptidase or on post-translational cleavage. Although this endopeptidase cleaved on the COOH side of an alanine residue, it was not inhibited by elastatinal. However, it was inhibited by high levels of chymostatin and by some serine protease inhibitors.
Secretory proteins and polypeptide hormones are synthesized on membrane-bound polyribosomes and pass through the membranes into the lumen of the rough endoplasmic reticulum (RER) (1) . Some insight into the mechanism of this transfer has been gathered by studying the primary translation products of mRNAs encoding these proteins. The initial products of mRNA translation for many secretory proteins were observed to be larger than the mature forms of the proteins found within the RER and contained an NH2-terminal pre-segment . Milstein et al. (3) and Blobel and Dobberstein (5) suggested that these pre-segments might act as "signals" allowing binding of the nascent peptide chains to RER membranes. During elongation, the growing polypeptide would be "driven" through the membrane and sequestered within RER vesicles. The presegment would be proteolytically removed during translation, resulting in conversion of the nascent pre-protein to the stable intracellular form of the protein.
Many recent studies have provided evidence to support some aspects of this proposal. Precursor proteins with hydrophobic NH2-terminal pre-pieces have been found after in vitro translations of mRNAs coding for several immunoglobulin light chains (3) (4) (5) (6) , polypeptide hormones (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) , pancreatic zymogens (7), rat liver albumin (21, 22) , oviduct secretory proteins (19) , bacterial proteins (23) , insect mellitin (24) , and ovine caseins (25) . The amino acid sequences of the pre-segments of many of these pre-proteins have been partially or completely determined and contain a high percentage of hydrophobic residues. However, the sequences are not homologous, even for pre-proteins derived from the same tissues, species, or cell types, and there is marked variability in length and amino acid sequence of the COOH-terminal section of the pre-segment. At least one secreted protein, moreover, did not have a NH2-terminal pre-segment (20) . Removal of the pre-portion (processing or cleavage) and sequestration of completed and processed forms of secretory proteins occurred if RER membranes were added to the in vitro translation reactions (5, 10, 12, 13, 15, 22, 26, 27) . Amino-terminal sequence analyses of the processed forms of several polypeptide hormones (10, 13, 15) and albumin (22) demonstrated that the NH2-terminal sequence of the cleaved products was identical with the NH2 terminus of the stable intracellular forms of the proteins. It was concluded that processing of nascent pre-proteins (i) occurred during translation when the nascent chains were about 70 amino acids long, (ii) was inhibited by certain detergents that lyse membranes and (in the ascites system) by calcium ions, and (iii) did not occur after release of completed pre-proteins from ribosomes. More recently, Jackson and Blobel (28) showed that a detergent extract of dog pancreas RER would process completed nascent chains (post-translational processing).
We have pursued the study of processing of pre-proteins by translating the mRNA encoding human placental lactogen (hPL) in vitro. Membrane-dependent processing of nascent pre-hPL was inhibited by chymostatin, an inhibitor of proteases with chymotryptic-like activity (29) . Further studies using protease inhibitors and a direct assay for protease activity suggested that the pre-protein processing enzyme was an endopeptidase that cleaved on the COOH side of alanine residues, but was not an elastase-like enzyme.
MATERIALS AND METHODS

Is5S
]Methionine (450-1200 Ci/mmol, 1 Ci = 3.7 X 1010 becquerels) was purchased from Amersham. Chymostatin, leupeptin, antipain, and elastatinal were provided by the United States-Japan Cooperative Cancer Research Program. Bestatin was obtained from H. Umezawa (Institute of Microbial Chemistry, Tokyo, Japan).
Placental RNA Preparation. Total RNA from fresh human placenta was isolated by phenol extraction as described (12) .
The A260/A28o ratio was 1.9:1. (Absorbance of all solutions was measured in cuvettes with a 1-cm path length.)
In Vitro Translation Reactions. Wheat germ lysates were prepared by the method of Marcu and Dudock (30) and contained 95-120 A260 units and 22-27 mg of protein per ml. Cell-free protein synthesis was performed with wheat germ lysates and fractionated ascites cell lysates (12, 21) .
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. 4225 Membrane Fraction Isolation. A membrane fraction from ascites cell lysates was isolated as described (12) . RER membranes from dog pancreas were prepared and stripped of ribosomes as described (5, 28) . Rat liver RER was stripped of ribosomes as described for-dog pancreas membranes (5) .
Cotranslational Cleavage of Pre-hPL. Membrane preparations were added to translation reaction mixtures prior to initiation of translation by addition of placental RNA. Various protease inhibitors, prepared as stock solutions (10 mg/ml) in dimethylsulfoxide, were added to the translation reactions before either membranes or RNA. Translation reactions with added dimethyl sulfoxide alone served as controls.
Solubilization of Cleavage Activity from Dog Pancreas Membranes and Post-Translational Cleavage of Pre-hPL. Total microsomes were prepared from fresh dog pancreas as described (28) . The microsomes were suspended in 20 mM Hepes buffer, pH 7.6/50 mM NaCl and sodium deoxycholate was added to a final concentration of 0.5%. After centrifugation at 100,000 X gav for 3 hr at 40C, the resulting supernatant fluid ("deoxycholate extract"; 15 mg of protein per ml) was aspirated and stored in liquid nitrogen. [-'S]Methionine-labeled pre-hPL formed in translation reactions (see above) was stored at -20'C. Aliquots of the labeled translation reactions and the deoxycholate extract were mixed and incubated for 30 min at room temperature (post-translational cleavage reaction).
Analysis of Products. The a5S-labeled products of in vitro translation reactions and of cleavage reactions were analyzed by sodium dodecyl sulfate (NaDodSO4) gel electrophoresis on 15% or 20% polyacrylamide gels (12, 21) . Dried gels were subjected to autoradiography for hr.
Direct Assays for Protease Activity. The peptide substrates, 7-(N-carbobenzyloxy L-glycylglycylargininamido)-4-methylcoumarin trifluoroacetate salt (Cbz-Gly-Gly-Arg-AMC), 7-(alanylalanylphenylalaninamido)-4-methylcoumarin trifluoroacetate (Ala-Ala-Phe-AMC), its succinyl derivative (succinyl-Ala-Ala-Phe-AMC), and 7-(N-acetylalanylalanylprolylalaninamido)-4-methylcoumarin (Ac-Ala-Ala-Pro-Ala-AMC), and both Phe-AMC and Ala-AMC were prepared by the methods of Zimmerman et al. (31, 32) . Activities of the deoxycholate extract (25 gl) against these substrates (0.2 mM) at 250C were determined in 50 mM 2-1[tris(hydroxymethyl)-methyl]aminolethanesulfonate (Tes), pH 7.5/5% dimethyl sulfoxide in a final volume of 0.5 ml. Fluorescence of the 7-amino-4-methylcoumarin (AMC) produced was determined as described (32) . The instrument was standardized such that 10 nM AMC gave 1.0 fluorescence unit. Inhibitors dissolved in dimethyl sulfoxide were added to the substrate prior to the addition of the deoxycholate extract. Residual enzyme activity was compared to that of a control to which equal concentrations of dimethyl sulfoxide without inhibitor had been added.
The products of neutral endopeptidase-like activity were identified after 16-hr incubations of deoxycholate extract with succinyl-Ala-Ala-Phe-AMC (0.2 mM) in a final volume of 1 ml at 250C. Fluorescent reaction products were extracted with an equal volume of toluene; the solvent layer was evaporated to dryness over nitrogen, redissolved in chloroform/methanol, 2:1 (vol/vol), and spotted on Silica Gel G thin-layer chromatography plates. Chromatograms were developed with isopropanol/hexane, 60:40 (vol/vol). Reaction extension of 25 amino acids (12, 13) (see Fig. 1 , lane 1). When stripped dog pancreas RER membranes were added to the translation reaction, pre-hPL was converted to a smaller form having the same mobility as authentic hPL (Fig. 1, lanes 2 and  3) . Nearly complete conversion of pre-hPL was demonstrated at higher concentrations of membranes. Stripped rat liver RER membranes also converted pre-hPL to mature hPL (Fig. 1, lane  4) . Both membrane preparations reduced the efficiency of translation of hPL mRNA (up to 80%) (data not shown). We have previously demonstrated that ascites membranes completely converted pre-hPL to hPL in this translation system (12, 26) .
Translation of hPL mRNA in wheat germ lysates produced pre-hPL (ref. 13, and Fig. 1, lane 5) . Addition of membranes derived from dog pancreas (lane 6) and rat liver membranes (data not shown) to this translation system also resulted in removal of the pre-segment, producing authentic hPL. Again, however, the efficiency of translation was reduced by the membrane preparations (approximately 50%). Moreover, only about 20% of pre-hPL was converted to hPL. These results demonstrated that any of three different mammalian tissues provided a source of the cleavage enzyme(s).
Characterization of Type of Protease(s) Involved in Cleavage by Use of Protease Inhibitors. Based on the known amino acid sequences of pre-segments, several authors (6, 19, 22, 25) have suggested that an elastase-like protease might process pre-proteins. To evaluate this possibility, we incubated hPL mRNA, membranes containing the cleavage enzyme, and various peptide protease inhibitors (29) in translation reactions.
Translation of hPL mRNA in ascites extracts in the absence of membranes resulted in formation of pre-hPL (Fig. 2, lane 4) . In the presence of ascites membranes, hPL was formed instead (lane 1). Cleavage of pre-hPL to hPL was inhibited by chymostatin (lanes 2, 3, and 5) by at least 50%. Dimethyl sulfoxide alone (lane 6) did not inhibit cleavage. Similar experiments with antipain, leupeptin, and elastatinal did not show detectable inhibition of processing of pre-hPL (data not shown).
Translation of hPL mRNA was also performed in wheat germ lysates containing dog pancreas membranes and protease inhibitors (Fig. 3) mg/ml), we analyzed the products of translation as in Fig. 3 .
Then the gels were sliced and the radioactivity in the pre-hPL and hPL bands were determined. (31, 32) . No significant activity against either Ac-Ala-Ala-ProAla-AMC or Cbz-Gyl-Gly-Arg-AMC (substrates for elastase and trypsin-like proteases, respectively) was detected. However the results (Table 1) Inhibition of release of AMC with these compounds was due to inhibition of aminopeptidase or endopeptidase or both (see Fig. 4 ). § This level of chymostatin does not significantly inhibit either aminopeptidase or endopeptidase activity.
observed. Because this substrate was blocked at the'NH2 terminus, an endoproteolytic event was required; but because aminopeptidase activity was present in the extract, its action on a partially cleaved intermediate might then release free AMC. In order to determine whether an intermediate was present, we incubated succinyl-Ala-Ala-Phe-AMC and deoxycholate extract in the presence or absence of bestatin and analyzed the products by thin-layer chromatography. In the absence of bestatin, most of the fluorescence migrated with the same RF as free AMC (Fig. 4, lane 2) although some material comigrated with Phe-AMC. Note that free AMC has a fluorescent intensity at least 100-fold greater than its peptide derivatives. However, in the presence of bestatin (lane 4), the major fluorescent product formed comigrated with Phe-AMC, but a small amount of free AMC was still observed. No detectable material cochromatographed with either Ala-AlaPhe-AMC or Ala-Phe-AMC. These results showed that at least two proteases were present in the deoxycholate extract-an aminopeptidase, which was inhibited by bestatin, and an endopeptidase, which cleaved the substrate between the Ala and the Phe residues.
-The product analysis in Fig. 4 also suggested that a small amount of a protease that directly cleaved the substrate between Phe and AMC was also present in the deoxycholate extract. Indeed, small amounts of free AMC -were released when deoxycholate extract, succinyl-Ala-Ala-Phe-AMC, and bestatin were incubated. Chymostatin at 25 Ag/ml, a concentration not inhibiting the Ala-Phe cleavage, abolished this activity (data not shown), suggesting that some chymotrypsin-like activity also existed in this preparation. Preliminary results from chromatography of the deoxycholate extract on Sephadex G-100 showed that the chymotrypsin-like activity could be readily separated from the aminopeptidase and Ala-Phe endopeptidase, which cochromatograph on this column. Furthermore, the Ala-Phe endopeptidase was inhibited by high levels of chymostatin (300-500 Atg/ml) as compared to the low levels required to inhibit the chymotrypsin-like activity (25 pg/mI).
We then compared the affects of several protease inhibitors on the peptidase activities in the crude deoxycholate extract. Activity against Phe-AMC (the aminopeptidase) was blocked by bestatin, 1,10-phenanthroline, and high levels of chymostatin and elastatinal, but not by serine protease inhibitors. Overall activity against succinyl-Ala-Ala-Phe-AMC was inhibited by bestatin, chymostatin, phenylmethylsulfonyl fluoride, N-carbobenzyloxy-L-phenylethyl chloromethyl ketone, and 1,10-phenanthroline. Absolute kinetic interpretation of the inhibitor data will have to await separation and purification of the aminopeptidase, endopeptidase, and chymotryptic-like activities.
DISCUSSION
We have previously shown that the initial product of translation of hPL mRNA in vitro was pre-hPL containing an extension of 25 amino acid residues on the NH2 terminus of serum hPL (13) . Addition of an ascites membrane preparation to the in vitro translation system resulted in proteolytic conversion of nascent pre-hPL to mature hPL. The accuracy of conversion was proved by NH2-terminal sequence analysis of the cleaved (processed) product, which had the precise NH2-terminal sequence of hPL (13) . The results reported here provided evidence that processing of pre-hPL to hPL occurred in both wheat germ and ascites translation assays if ascites membranes, stripped rat liver RER membranes, or dog pancreas RER membranes were present (Fig. 1) .
Our previous results proved that ascites membranes correctly processed two pre-proteins (pre-hPL and pre-proalbumin) to their stable intracellular forms (13, 22) . Moreover, dog pancreas membranes correctly processed precursors of several polypeptide hormones (10, 15) and immunoglobulin light chains (5) . However, the amino acid sequences of the pre-segments of the pre-proteins processed were quite different (10, 13, 15, 21) . The final peptide bond that was split during the conversion of these precursors to the smaller forms also varied. The cleavage enzyme(s) in either membrane preparation thus recognized and acted upon different substrates (the different nascent pre-protein chains). These results suggested that the cleavage enzyme(s) might recognize some three-dimensional conformation common to the NH2-terminal portion of the pre-proteins, rather than the primary amino acid sequence (6, 19, 25) .
To provide some idea of the nature, classification, and specificity of the protease(s) involved in processing of preproteins, we studied the effects of several protease inhibitors on the processing of pre-hPL nascent chains (Figs. 2 and 3) . Our experiments demonstrated that high levels of chymostatin (29) inhibited processing. Elastatinal, a potent inhibitor of elastase-like proteases (29) , did not inhibit cleavage of pre-hPL.
Other protease inhibitors of similar structure but of different specificities also did not inhibit the cleavage-i.e., leupeptin and antipain. This pattern of inhibition was the same for both the ascites and the dog pancreatic membranes. However, because crude membranes were used in these studies, it is possible that the inhibition was mediated through an indirect mechanism. Chymostatin contains a peptide-like structure similar to the amino acid sequence of the nascent pre-segment and might block the membrane-binding site. Alternatively, chymostatin could perturb some membrane-enzyme interaction necessary for processing activity.
Studies of the pre-protein processing enzymes with intact, crude membranes were limited by the requirements of the lysates necessary to allow efficient translation, the rapidity of the cleavage reaction, and the reported inability to process completed pre-proteins (5, 10, 12, 15, 26 (31, 32) also reduced the endopeptidase activity present in the deoxycholate extract. These results did not prove that the measured proteolytic activity (and its inhibition) was due to the proteases involved in cleavage. However, the endopeptidase activity was inhibited by chymostatin but not by elastatinal or bestatin in a manner similar to the inhibition of cleavage activity (Fig. 3 ). This correlation suggested that the direct assay was measuring proteolytic activity (the Ala-Phe endopeptidase) identical with the cleavage enzyme. Proof of this identity will be possible if, during purification of the processing enzyme, cleavage activity and the Ala-Phe endopeptidase activity copurify. The results presented here allowed several conclusions concerning the protease(s) involved in processing of precursor proteins. (i) The cleavage enzymes were present in ascites tumor membranes and stripped rat liver and dog pancreas RER membranes. (ii) Processing was inhibited by chymostatin, an inhibitor of chymotrypsin and other endopeptidases. (iii) Cleavage activity could be dissociated from membranes and occurred post-translationally. (iv) The deoxycholate extract of dog pancreas membranes contained aminopeptidase activity, which was not required for processing activity. (v) The major endoprotease present cleaved the Ala-Phe bond of the succinyl-Ala-Ala-Phe-AMC substrate. This peptide bond specificity would be compatible with cleavage after the several aliphatic residues (Ala, Ser, and Gly) that occur at the COOH terminus of pre-segments. (vi) Processing activity could not be due to a typical elastase because no cleavage of fluorogenic substrate rapidly hydrolyzed by polymorphonuclear leukocyte and pancreatic elastases was present and because elastatinal did not inhibit processing.
Use of synthetic peptide substrates should give insight into the number and types of proteolytic events that occur during pre-protein processing and will facilitate purification of the cleavage enzyme(s).
